141 related articles for article (PubMed ID: 10533812)
1. Syntheses and SH-enzyme inhibitory activities of new epoxysuccinic acid piperazine derivatives against mu-calpain and cathepsin B.
Inoue J; Yoshida Y; Nakamura M; Cui YS; Nagao Y
Drug Des Discov; 1999 Aug; 16(2):165-9. PubMed ID: 10533812
[TBL] [Abstract][Full Text] [Related]
2. Probing of primed and unprimed sites of calpains: Design, synthesis and evaluation of epoxysuccinyl-peptide derivatives as selective inhibitors.
Dókus LE; Menyhárd DK; Tantos Á; Hudecz F; Bánóczi Z
Eur J Med Chem; 2014 Jul; 82():274-80. PubMed ID: 24915003
[TBL] [Abstract][Full Text] [Related]
3. Novel peptidyl alpha-keto amide inhibitors of calpains and other cysteine proteases.
Li Z; Ortega-Vilain AC; Patil GS; Chu DL; Foreman JE; Eveleth DD; Powers JC
J Med Chem; 1996 Sep; 39(20):4089-98. PubMed ID: 8831774
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of each catalytic subsite of cathepsin B for inhibitory activity based on inhibitory activity-binding mode relationship of epoxysuccinyl inhibitors by X-ray crystal structure analyses of complexes.
Watanabe D; Yamamoto A; Tomoo K; Matsumoto K; Murata M; Kitamura K; Ishida T
J Mol Biol; 2006 Oct; 362(5):979-93. PubMed ID: 16950396
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of 4-aryl-4-oxobutanoic acid amides as calpain inhibitors.
Zhang Y; Jung SY; Jin C; Kim ND; Gong P; Lee YS
Bioorg Med Chem Lett; 2009 Jan; 19(2):502-7. PubMed ID: 19041242
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of chromone carboxamides as calpain inhibitors.
Lee KS; Seo SH; Lee YH; Kim HD; Son MH; Chung BY; Lee JY; Jin C; Lee YS
Bioorg Med Chem Lett; 2005 Jun; 15(11):2857-60. PubMed ID: 15911268
[TBL] [Abstract][Full Text] [Related]
7. A novel series of urea-based peptidomimetic calpain inhibitors.
Sanders ML; Donkor IO
Bioorg Med Chem Lett; 2006 Apr; 16(7):1965-8. PubMed ID: 16412635
[TBL] [Abstract][Full Text] [Related]
8. Design, Synthesis, and Structure-Activity Relationship Study of Epoxysuccinyl-Peptide Derivatives as Cathepsin B Inhibitors.
Zhang X; Yang X; Wang H; Li S; Guo K; Jiang D; Xiao J; Liang D
Biol Pharm Bull; 2017 Aug; 40(8):1240-1246. PubMed ID: 28502922
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and calpain inhibitory activity of peptidomimetic compounds with constrained amino acids at the P2 position.
Donkor IO; Korukonda R
Bioorg Med Chem Lett; 2008 Sep; 18(17):4806-8. PubMed ID: 18694642
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of a small library of diketopiperazines as potential inhibitors of calpain.
Zeng Y; Li Q; Hanzlik RP; Aubé J
Bioorg Med Chem Lett; 2005 Jun; 15(12):3034-8. PubMed ID: 15896956
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, calpain inhibitory activity, and cytotoxicity of P2-substituted proline and thiaproline peptidyl aldehydes and peptidyl alpha-ketoamides.
Korukonda R; Guan N; Dalton JT; Liu J; Donkor IO
J Med Chem; 2006 Aug; 49(17):5282-90. PubMed ID: 16913717
[TBL] [Abstract][Full Text] [Related]
12. Probing the potential of platinum(II) complexes for the inhibition of thiol-dependent enzymatic activity.
van Zutphen S; Kraus M; Driessen C; van der Marel GA; Overkleeft HS; Reedijk J
J Inorg Biochem; 2005 Jun; 99(6):1384-9. PubMed ID: 15869797
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors.
Meara JP; Rich DH
J Med Chem; 1996 Aug; 39(17):3357-66. PubMed ID: 8765519
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of calpain inhibitory 6-pyridone 2-carboxamide derivatives.
Lee KY; Lee KS; Jin C; Lee YS
Eur J Med Chem; 2009 Mar; 44(3):1331-4. PubMed ID: 18396356
[TBL] [Abstract][Full Text] [Related]
15. Cyclopropenone-containing cysteine proteinase inhibitors. Synthesis and enzyme inhibitory activities.
Ando R; Sakaki T; Morinaka Y; Takahashi C; Tamao Y; Yoshii N; Katayama S; Saito K; Tokuyama H; Isaka M; Nakamura E
Bioorg Med Chem; 1999 Apr; 7(4):571-9. PubMed ID: 10353636
[TBL] [Abstract][Full Text] [Related]
16. Derivatives of 3-sec-butyl-1-oxo-2,3-dihydroisoquinoline as inhibitors of mu-calpain.
Chicharro R; Alonso M; Mazo MT; Arán VJ; Herradón B
ChemMedChem; 2006 Jul; 1(7):710-4. PubMed ID: 16902923
[No Abstract] [Full Text] [Related]
17. Structural basis of inhibition of cysteine proteases by E-64 and its derivatives.
Matsumoto K; Mizoue K; Kitamura K; Tse WC; Huber CP; Ishida T
Biopolymers; 1999; 51(1):99-107. PubMed ID: 10380357
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of synthetic chalcone derivatives as competitive dual inhibitors against μ-calpain and cathepsin B through the downregulation of tau phosphorylation and insoluble Aβ peptide formation.
Jeon KH; Lee E; Jun KY; Eom JE; Kwak SY; Na Y; Kwon Y
Eur J Med Chem; 2016 Oct; 121():433-444. PubMed ID: 27318120
[TBL] [Abstract][Full Text] [Related]
19. Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.
Donkor IO; Korukonda R; Huang TL; LeCour L
Bioorg Med Chem Lett; 2003 Mar; 13(5):783-4. PubMed ID: 12617890
[TBL] [Abstract][Full Text] [Related]
20. E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group.
Schaschke N; Assfalg-Machleidt I; Machleidt W; Turk D; Moroder L
Bioorg Med Chem; 1997 Sep; 5(9):1789-97. PubMed ID: 9354234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]